Suppr超能文献

蛋白激酶C-θ(PKCθ)的催化结构域晶体结构

Catalytic domain crystal structure of protein kinase C-theta (PKCtheta).

作者信息

Xu Zhang-Bao, Chaudhary Divya, Olland Stephane, Wolfrom Scott, Czerwinski Robert, Malakian Karl, Lin Laura, Stahl Mark L, Joseph-McCarthy Diane, Benander Christina, Fitz Lori, Greco Rita, Somers William S, Mosyak Lidia

机构信息

Department of Chemical and Screening Sciences, Inflammation Department, Wyeth Research, Cambridge, Massachusetts 02140, USA.

出版信息

J Biol Chem. 2004 Nov 26;279(48):50401-9. doi: 10.1074/jbc.M409216200. Epub 2004 Sep 13.

Abstract

A member of the novel protein kinase C (PKC) subfamily, PKC, is an essential component of the T cell synapse and is required for optimal T cell activation and interleukin-2 production. Selective involvement of PKC in TCR signaling makes this enzyme an attractive therapeutic target in T cell-mediated disease processes. In this report we describe the crystal structure of the catalytic domain of PKC at 2.0-A resolution. Human recombinant PKC kinase domain was expressed in bacteria as catalytically active phosphorylated enzyme and co-crystallized with its subnanomolar, ATP site inhibitor staurosporine. The structure follows the classic bilobal kinase fold and shows the enzyme in its active conformation and phosphorylated state. Inhibitory interactions between conserved features of staurosporine and the ATP-binding cleft are accompanied by closing of the glycine-rich loop, which also maintains an inhibitory arrangement by blocking the phosphate recognition subsite. The two major phosphorylation sites, Thr-538 in the activation loop and Ser-695 in the hydrophobic motif, are both occupied in the structure, playing key roles in stabilizing active conformation of the enzyme and indicative of PKC autocatalytic phosphorylation and activation during bacterial expression. The PKC-staurosporine complex represents the first kinase domain crystal structure of any PKC isotypes to be determined and as such should provide valuable insight into PKC specificity and into rational drug design strategies for PKC selective leads.

摘要

新型蛋白激酶C(PKC)亚家族的成员PKC是T细胞突触的重要组成部分,是最佳T细胞活化和白细胞介素-2产生所必需的。PKC在TCR信号传导中的选择性参与使该酶成为T细胞介导的疾病过程中有吸引力的治疗靶点。在本报告中,我们描述了PKC催化结构域在2.0埃分辨率下的晶体结构。人重组PKC激酶结构域在细菌中作为具有催化活性的磷酸化酶表达,并与其亚纳摩尔ATP位点抑制剂星形孢菌素共结晶。该结构遵循经典的双叶激酶折叠,显示该酶处于活性构象和磷酸化状态。星形孢菌素的保守特征与ATP结合裂隙之间的抑制性相互作用伴随着富含甘氨酸环的闭合,这也通过阻断磷酸识别亚位点维持抑制性排列。两个主要的磷酸化位点,即活化环中的苏氨酸-538和疏水基序中的丝氨酸-695,在结构中均被占据,在稳定酶的活性构象中起关键作用,并表明PKC在细菌表达过程中的自催化磷酸化和活化。PKC-星形孢菌素复合物代表了已确定的任何PKC同工型的首个激酶结构域晶体结构,因此应为PKC特异性以及PKC选择性先导化合物的合理药物设计策略提供有价值的见解。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验